| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0fb1603da5846cf047d0b95a366c6e48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_570f4a2b68db687a491406ddc6c9e8aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6a7f3068c412965d1d753bd152f94fe |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6087
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5123
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5161
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6939
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate |
2012-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22b08074e218f9b3fd932ac48177a203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31d8b0f403cc928e840aa1c5eb20451a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90558528b46291a31dabeb8ab35a5fd9 |
| publicationDate |
2014-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2708237-A1 |
| titleOfInvention |
Pharmaceutical composition for its use in the preventive treatment of infections caused by an intracellular pathogen, more particularly Toxoplasma gondii |
| abstract |
The present invention relates to a pharmaceutical composition for its use in the prophylactic treatment in a patient against an intracellular pathogen, said composition comprising a solid nanoparticle comprising a cationic-polysaccharide solid core, said core being porous and loaded with at least an anionic phospholipid and at least an antigen coming obtained from said pathogen. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022008848-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-3112284-A1 |
| priorityDate |
2012-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |